BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11968006)

  • 1. Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor.
    Maldonado E; Cabrejos ME; Banks L; Allende JE
    J Cell Biochem; 2002; 85(4):663-9. PubMed ID: 11968006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
    Hermonat PL; Santin AD; Zhan D
    J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.
    Massimi P; Pim D; Storey A; Banks L
    Oncogene; 1996 Jun; 12(11):2325-30. PubMed ID: 8649772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of p53 transcriptional activity by the HPV E7 proteins.
    Massimi P; Banks L
    Virology; 1997 Jan; 227(1):255-9. PubMed ID: 9007083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle.
    Massimi P; Banks L
    Virology; 2000 Oct; 276(2):388-94. PubMed ID: 11040129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the interaction between human papillomavirus type 16 E7 and the TATA-binding protein, TBP.
    Phillips AC; Vousden KH
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():905-9. PubMed ID: 9129664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
    Massimi P; Pim D; Banks L
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2607-13. PubMed ID: 9349482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity.
    Prathapam T; Kühne C; Banks L
    Oncogene; 2001 Nov; 20(52):7677-85. PubMed ID: 11753645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110.
    Mazzarelli JM; Atkins GB; Geisberg JV; Ricciardi RP
    Oncogene; 1995 Nov; 11(9):1859-64. PubMed ID: 7478615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.
    Chien WM; Parker JN; Schmidt-Grimminger DC; Broker TR; Chow LT
    Cell Growth Differ; 2000 Aug; 11(8):425-35. PubMed ID: 10965847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II.
    Firzlaff JM; Galloway DA; Eisenman RN; Lüscher B
    New Biol; 1989 Oct; 1(1):44-53. PubMed ID: 2562189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the HPV E7 proteins with the pCAF acetyltransferase.
    Avvakumov N; Torchia J; Mymryk JS
    Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of yeast TBP by protein kinase CK2 reduces its specific binding to DNA.
    Maldonado E; Allende JE
    FEBS Lett; 1999 Jan; 443(3):256-60. PubMed ID: 10025943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signals for TBP/TATA box recognition.
    Bareket-Samish A; Cohen I; Haran TE
    J Mol Biol; 2000 Jun; 299(4):965-77. PubMed ID: 10843851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA and protein footprinting analysis of the modulation of DNA binding by the N-terminal domain of the Saccharomyces cerevisiae TATA binding protein.
    Gupta S; Cheng H; Mollah AK; Jamison E; Morris S; Chance MR; Khrapunov S; Brenowitz M
    Biochemistry; 2007 Sep; 46(35):9886-98. PubMed ID: 17683121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV-18 E6 inhibits p53 DNA binding activity regardless of the oligomeric state of p53 or the exact p53 recognition sequence.
    Thomas M; Massimi P; Banks L
    Oncogene; 1996 Aug; 13(3):471-80. PubMed ID: 8760288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific in vitro interaction between papillomavirus E2 proteins and TBP-associated factors.
    Carrillo E; Garrido E; Gariglio P
    Intervirology; 2004; 47(6):342-9. PubMed ID: 15564746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fluorescence anisotropy study of DNA binding by HPV-11 E2C protein: a hierarchy of E2-binding sites.
    Alexander KA; Phelps WC
    Biochemistry; 1996 Jul; 35(30):9864-72. PubMed ID: 8703960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein.
    Zwerschke W; Joswig S; Jansen-Dürr P
    Oncogene; 1996 Jan; 12(1):213-20. PubMed ID: 8552395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NC2alpha interacts with BTAF1 and stimulates its ATP-dependent association with TATA-binding protein.
    Klejman MP; Pereira LA; van Zeeburg HJ; Gilfillan S; Meisterernst M; Timmers HT
    Mol Cell Biol; 2004 Nov; 24(22):10072-82. PubMed ID: 15509807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.